Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rectal Prolapse | 2 | 2024 | 23 | 1.170 |
Why?
|
| Fecal Incontinence | 2 | 2014 | 86 | 0.480 |
Why?
|
| Electric Stimulation Therapy | 1 | 2014 | 81 | 0.400 |
Why?
|
| Rectocele | 1 | 2010 | 3 | 0.330 |
Why?
|
| Uterine Prolapse | 1 | 2010 | 14 | 0.330 |
Why?
|
| Pelvic Floor | 1 | 2010 | 22 | 0.330 |
Why?
|
| Fasciotomy | 1 | 2008 | 12 | 0.290 |
Why?
|
| Hernia, Ventral | 1 | 2008 | 24 | 0.290 |
Why?
|
| Appendicitis | 1 | 2008 | 130 | 0.260 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 264 | 0.220 |
Why?
|
| Pancreaticojejunostomy | 1 | 1998 | 8 | 0.150 |
Why?
|
| Surgical Wound Dehiscence | 1 | 1998 | 22 | 0.150 |
Why?
|
| Aged, 80 and over | 6 | 2014 | 7635 | 0.130 |
Why?
|
| Pancreas | 1 | 1998 | 329 | 0.120 |
Why?
|
| Ischemia | 1 | 1998 | 409 | 0.120 |
Why?
|
| Lumbosacral Plexus | 1 | 2014 | 6 | 0.110 |
Why?
|
| Length of Stay | 2 | 2008 | 1215 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2014 | 10811 | 0.090 |
Why?
|
| Defecography | 1 | 2010 | 3 | 0.080 |
Why?
|
| Feedback, Physiological | 1 | 2010 | 77 | 0.080 |
Why?
|
| Manometry | 1 | 2010 | 95 | 0.080 |
Why?
|
| Urinary Incontinence | 1 | 2010 | 66 | 0.080 |
Why?
|
| Aged | 6 | 2014 | 23961 | 0.080 |
Why?
|
| Anal Canal | 1 | 2010 | 97 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2014 | 15657 | 0.080 |
Why?
|
| Endosonography | 1 | 2010 | 156 | 0.070 |
Why?
|
| Pancreatitis | 2 | 1999 | 134 | 0.070 |
Why?
|
| Surgical Mesh | 1 | 2008 | 47 | 0.070 |
Why?
|
| Electromyography | 1 | 2010 | 400 | 0.070 |
Why?
|
| Middle Aged | 6 | 2014 | 33479 | 0.070 |
Why?
|
| Suture Techniques | 1 | 2008 | 122 | 0.070 |
Why?
|
| Humans | 11 | 2024 | 137585 | 0.060 |
Why?
|
| Intestine, Small | 2 | 1997 | 156 | 0.060 |
Why?
|
| Adult | 6 | 2014 | 37929 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2008 | 2654 | 0.060 |
Why?
|
| Female | 8 | 2014 | 73304 | 0.060 |
Why?
|
| Recurrence | 1 | 2008 | 1060 | 0.060 |
Why?
|
| Surgical Wound Infection | 1 | 2008 | 307 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 5131 | 0.060 |
Why?
|
| Adenocarcinoma | 2 | 2002 | 940 | 0.060 |
Why?
|
| Comorbidity | 1 | 2008 | 1622 | 0.050 |
Why?
|
| Male | 7 | 2014 | 67762 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 2 | 1999 | 938 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 2828 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2002 | 258 | 0.040 |
Why?
|
| Rectal Neoplasms | 1 | 2001 | 149 | 0.040 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 1998 | 32 | 0.040 |
Why?
|
| Quality of Life | 1 | 2010 | 2892 | 0.040 |
Why?
|
| Genes, ras | 1 | 1997 | 97 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 1997 | 75 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 1998 | 413 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 1998 | 474 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2002 | 1079 | 0.030 |
Why?
|
| Laparoscopy | 1 | 1999 | 466 | 0.030 |
Why?
|
| Adolescent | 2 | 2008 | 21513 | 0.030 |
Why?
|
| Obesity | 1 | 2008 | 2992 | 0.030 |
Why?
|
| Cell Cycle | 1 | 1997 | 601 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2008 | 11074 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1997 | 528 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 1997 | 623 | 0.020 |
Why?
|
| Proteins | 1 | 1997 | 1009 | 0.020 |
Why?
|
| Apoptosis | 1 | 1997 | 2553 | 0.020 |
Why?
|
| Child | 1 | 2008 | 21935 | 0.020 |
Why?
|
| Mice, Transgenic | 3 | 1997 | 2167 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 1997 | 18 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2002 | 1389 | 0.020 |
Why?
|
| Colectomy | 1 | 2002 | 100 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2001 | 94 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2001 | 268 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2002 | 686 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2001 | 208 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 1997 | 1991 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1999 | 66 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2002 | 1266 | 0.010 |
Why?
|
| Pancreatic Ducts | 1 | 1999 | 85 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2001 | 404 | 0.010 |
Why?
|
| Defensins | 1 | 1997 | 4 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1997 | 24 | 0.010 |
Why?
|
| Peyer's Patches | 1 | 1997 | 7 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1997 | 45 | 0.010 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 1997 | 15 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 1997 | 43 | 0.010 |
Why?
|
| Jejunum | 1 | 1997 | 31 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 1997 | 56 | 0.010 |
Why?
|
| Diphtheria Toxin | 1 | 1997 | 66 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1997 | 443 | 0.010 |
Why?
|
| Integrins | 1 | 1997 | 95 | 0.010 |
Why?
|
| Species Specificity | 1 | 1997 | 585 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 233 | 0.010 |
Why?
|
| Mice | 3 | 1997 | 17787 | 0.010 |
Why?
|
| Biopsy | 1 | 1999 | 1129 | 0.010 |
Why?
|
| Cell Lineage | 1 | 1997 | 350 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1999 | 759 | 0.010 |
Why?
|
| Ligands | 1 | 1997 | 664 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 1483 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1997 | 648 | 0.010 |
Why?
|
| Homeostasis | 1 | 1997 | 621 | 0.010 |
Why?
|
| Animals | 3 | 1997 | 36940 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1997 | 1164 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1999 | 2691 | 0.000 |
Why?
|
| Phenotype | 1 | 1997 | 3196 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1997 | 2607 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1997 | 5757 | 0.000 |
Why?
|